mirtazapine 30 mg

1 INDICATIONS AND USAGE Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. ( 1 )

apotex corp.

FDA Reported Adverse Reactions
`[1] nausea` `[2] fatigue` `[3] off label use` `[4] dyspnoea` `[5] diarrhoea` `[6] drug ineffective` `[7] headache` `[8] vomiting` `[9] pyrexia` `[10] fall`

2 years ago

OVAL PINK APO MI 30

2 years ago

APO MI 30 OVAL PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

MIRTAZAPINE tablets are supplied as:

MIRTAZAPINE Tablets, USP 15 mg are available for oral administration as pale yellow, oval-shaped, scored, film-coated tablets imprinted “APO” on one side and “MI” bisect “15” on the other side. They are supplied as follows: Bottles of 30 NDC 60505-0247-1 Bottles of 1,000 NDC 60505-0247-8

MIRTAZAPINE Tablets, USP 30 mg are available for oral administration as light pink, oval-shaped, scored, film-coated tablets imprinted “APO” on one side and “MI” bisect “30” on the other side. They are supplied as follows: Bottles of 30 NDC 60505-0248-1 Bottles of 1,000 NDC 60505-0248-8

MIRTAZAPINE Tablets, USP 45 mg are available for oral administration as white to off-white, oval-shaped, unscored, film-coated tablets imprinted “APO” on one side and “MI-45” on the other side. They are supplied as follows: Bottles of 30 NDC 60505-0249-1 Bottles of 1,000 NDC 60505-0249-8 Storage Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture.

More pills like OVAL APO MI 30

Related Pills

mirtazapine tablet film coated

apotex corp.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site